Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for Pulmonx (LUNG) over the last 6 years, with Q3 2025 value amounting to $40.9 million.

  • Pulmonx's Shares Outstanding (Diluted Average) rose 422.76% to $40.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.9 million, marking a year-over-year increase of 422.76%. This contributed to the annual value of $39.1 million for FY2024, which is 299.28% up from last year.
  • Per Pulmonx's latest filing, its Shares Outstanding (Diluted Average) stood at $40.9 million for Q3 2025, which was up 422.76% from $40.4 million recorded in Q2 2025.
  • Pulmonx's Shares Outstanding (Diluted Average)'s 5-year high stood at $40.9 million during Q3 2025, with a 5-year trough of $35.4 million in Q1 2021.
  • For the 5-year period, Pulmonx's Shares Outstanding (Diluted Average) averaged around $37.9 million, with its median value being $37.8 million (2023).
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first skyrocketed by 176225.07% in 2021, then skyrocketed by 203.28% in 2022.
  • Pulmonx's Shares Outstanding (Diluted Average) (Quarter) stood at $36.1 million in 2021, then increased by 2.68% to $37.1 million in 2022, then grew by 2.37% to $38.0 million in 2023, then rose by 2.99% to $39.1 million in 2024, then rose by 4.67% to $40.9 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $40.9 million for Q3 2025, versus $40.4 million for Q2 2025 and $40.0 million for Q1 2025.